Hcv patients given daa therapy away from elevated risk of developing liver cancer, study finds
New research presented now in the Liver Meeting® — held through the American Association for study regarding Liver Illnesses — found patients with hepatitis C taking direct-acting antiviral medication are in no greater risk for developing liver cancer than individuals who don’t go ahead and take medication. However, they could be in an elevated for …